Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
chimeric monoclonal antibody used to treat varioussolid tumours .
Etymologies
from Wiktionary, Creative Commons Attribution/Share-Alike License
Support
Help support Wordnik (and make this page ad-free) by adopting the word volociximab.
Examples
-
Biogen and Facet have had a working relationship since 2005 and have been jointly developing a multiple sclerosis drug target called daclizumab and another drug candidate called volociximab to treat solid tumors.
Philadelphia Business News - Local Philadelphia News | The Philadelphia Business Journal 2009
-
As for the rest of the pipeline, Facet is currently investigating volociximab in various open-label clinical trials in patients with advanced solid tumours, again with Biogen and is collaborating with Bristol-Myers Squibb on elotuzumab which is in Phase I studies for multiple myeloma.
-
The company's current clinical-stage programs consist of daclizumab for the treatment of multiple sclerosis, currently in a second phase 2 trial; volociximab, currently in phase 1 / 2 studies in ovarian and non-small cell lung cancer; elotuzumab, which is in three phase 1 studies in patients with multiple myeloma; and PDL192, which is in a phase 1 study in various solid tumors.
San Jose Business News - Local San Jose News | The Silicon Valley / San Jose Business Journal 2009
-
-- The revised offer provides insufficient value to our pipeline products, specifically daclizumab, elotuzumab, volociximab, TRU-016, PDL192 and PDL241, and our protein engineering technologies, particularly in light of the promising scientific data we recently presented.
-
As for the rest of the pipeline, Facet is currently investigating volociximab in various open-label clinical trials in patients with advanced solid tumours, again with Biogen and is collaborating with Bristol-Myers Squibb on elotuzumab which is in Phase I studies for multiple myeloma.
-
It also is in Phase I / II studies for volociximab in ovarian and non-small cell lung cancer and has a Phase I study of PDL-192 versus various solid tumors.
San Francisco Business News - Local San Francisco News | The San Francisco Business Times 2009
-
It also is in Phase I / II studies for volociximab in ovarian and non-small cell lung cancer and has a Phase I study of PDL-192 versus various solid tumors.
San Francisco Business News - Local San Francisco News | The San Francisco Business Times 2009
-
Daclizumab and volociximab are being developed in collaboration with
San Francisco Business News - Local San Francisco News | The San Francisco Business Times 2009
-
Daclizumab and volociximab are being developed in collaboration with
San Francisco Business News - Local San Francisco News | The San Francisco Business Times 2009
-
-- The revised offer provides insufficient value to our pipeline products, specifically daclizumab, elotuzumab, volociximab, TRU-016, PDL192 and PDL241, and our protein engineering technologies, particularly in light of the promising scientific data we recently presented.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.